Generic Drug Maker Ranbaxy Found Falsifying Data To FDA

Generic Drug Maker Ranbaxy Found Falsifying Data To FDA

The FDA has suspended all new drug applications from one of Ranbaxy’s plants in India—the Paonta Sahib plant—after “determining the facility was falsifying scientific data.” You may recall that last September the FDA banned the import of 30 popular generic meds made by Ranbaxy due in part to quality control issues from this very same plant. What do they think they are, a peanut butter factory?

FDA Bans Import Of 30 Popular Generic Drugs

FDA Bans Import Of 30 Popular Generic Drugs

The FDA has banned the import of 30 different generic drugs made by Ranbaxy due to unresolved ongoing concerns about quality controls in the manufacturing process. Some of them are popular, like a generic for Zocor. The complete list inside. If you’re taking any of the affected drugs, keep taking them. The FDA found no evidence to suggest any consumers are at risk. If you have concerns, consult your doctor.